Clinical Trials Directory

Trials / Completed

CompletedNCT04882644

Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD)

Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
All
Age
30 Years – 55 Years
Healthy volunteers
Not accepted

Summary

NAFLD is increasingly being identified in lean individuals, especially in Chinese population. Among the NAFLD patients, the lean NAFLD accounts for 15.9%-23.0%. Previous studies showed that the lean NAFLD individuals might have a higher risk of severe hepatic disease than those obese individuals. However, the effects of aerobic exercise on the reduction of liver fat content and metabolic risk factors in lean NAFLD individuals remain unknown. In this randomized controlled trial, we will examine the effect of a 3-month exercise training (aerobic exercise) on liver fat content and metabolic risk factors in lean NAFLD individuals.

Detailed description

The whole study is divided into four phases: recruitment phase, training phase (1 month, aim to gradually adapt patients to the target exercise intensity), implementation phase (3 months), and follow-up phase (9 months). And the subjects are randomly assigned to two groups: aerobic exercise intervention group and control group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAerobic ExerciseThe subjects conduct an aerobic exercise at 65-80% maximum oxygen consumption three times per week for 60 min/session (including 5 min warm-up and 5 min cool down) with treadmills, ellipticals, and rowing machine. The subjects attend health education sessions (eg, general health knowledge of NAFLD and metabolic diseases, and elements of a healthy lifestyle) monthly in the 12 months.

Timeline

Start date
2021-05-14
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2021-05-12
Last updated
2024-09-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04882644. Inclusion in this directory is not an endorsement.